Posts by Sandra Ansanay-Alex
Transmutex raises CHF 20 Million
The Geneva-based company, founded in 2019, has secured new funding to further develop its research into safer, cleaner and cheaper nuclear power generation. The technology could also have healthcare applications. Geneva-based nuclear engineering company Transmutex has secured CHF 20 Million in financing from New York-based venture capital funds Union Square Ventures and Steel…
Read MorePfizer Research Prize: 3 Researchers From The Swiss Health Valley Awarded
13 young researchers from Fribourg, Geneva, Basel, Bern, and Zurich have won a 2024 Pfizer Research Award. Since 1992, Pfizer Prize for Research has been awarded annually to young scientists conducting research at Swiss research institutes or hospitals. The award, is aimed at outstanding and pioneering contributions in pure and clinical research. Each awarded…
Read MoreThe Roger de Spoelberch Prize Awarded to a UNIGE Researcher
Professor Denis Jabaudon, Director of the Department of Basic Neuroscience and member of the Synapsy Center for Neuroscience Research in Mental Health (Faculty of Medicine), has won the Roger de Spoelberch Prize 2023 for his research into brain development. A specialist in the formation of cortical networks, Prof. Denis Jabaudon is also the…
Read MoreLonza Achieves Strong Financial Results in 2023 Amid Leadership Transition
The Swiss CDMO announces robust sales of CHF 6.7 billion, delivering 10.9%1 CER sales growth, and the nomination of Jean-Marc Huët to succeed Albert M. Baehny as chairman of the company. Lonza, a leading CDMO (Contract Development and Manufacturing Organization), has reported robust financial results for the year 2023. The company achieved sales…
Read MoreStämm chooses Valais to set up its European team
The Argentinian biomanufacturing innovator is launching its R&D facility at the BioArk in Monthey Founded in 2016 in Argentina, Stämm, now boasting a robust team of over 200 in Buenos Aires and San Francisco, specializes in harnessing nature-inspired, data-driven solutions to revolutionize bioprocessing. With the establishment of its new R&D facility in Western…
Read MorePhenomX Health and Issviva launch a programme to help women manage Stress and Sleep during Menopause
In a pioneering partnership, Issviva Menopause and the Swiss startup PhenomX Health have united their expertise to empower women navigating peri to post-menopause, offering a unique approach to tackle two prevalent challenges during this phase – sleep disruption and increased stress levels. In the UK, a staggering 85% of midlife women, constituting a…
Read MoreThe Lighthouse Partnership: a Swiss cooperation to propel AI-Guided Neuromodulation
This 4 years partnership is funded with CHF 18 Million from the Wyss Center, and involves EPFL Neuro X Institute, UNIGE Synapsy Centre for Neuroscience, and clinical partners at Campus Biotech. The Wyss Center for Bio and Neuroengineering has joined forces with the EPFL Neuro X Institute, UNIGE Synapsy Centre for Neuroscience, and…
Read MoreFluoSphera is awarded a CHF 1.1 million grant from Innosuisse
FluoSphera S.A., a biotechnology company developing versatile and disruptive in-vitro solutions for drug discovery to predict drug efficacy and safety under systemic conditions, today announced that its new innovation project together with EPFL and the University of Geneva (UNIGE) has been awarded a grant of CHF 1,100,000 Swiss francs from Innosuisse, the Swiss Innovation Agency.…
Read MoreMaven Health, NeoSens and NADUP supported by the FIT
Three life science projects have received support from the Foundation for Technological Innovation (FIT) in the form of Tech Grants: Maven Health and NeoSens from EPFL, and NADUP from UNIL will be able to continue developing their technologies with the backing of the Foundation. Maven Health – prevention and screening of metabolic diseases…
Read MoreFIT loans CHF 500,000 to Doppl and CHF 100,000 to Rea Diagnostics
DOPPL, a leader in organoid engineering for disease modelling and personalised medicine, has received a Tech Growth loan of CHF 500,000 from the Foundation for Technological Innovation (FIT), while Rea Diagnostics, specialising in the detection of premature births, has received a Tech Seed loan of CHF 100,000. DOPPL, organoids for the future of…
Read More